142 related articles for article (PubMed ID: 3900216)
1. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
[TBL] [Abstract][Full Text] [Related]
2. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
3. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
4. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy.
Doi T; Kanatsu K; Sekita K; Yoshida H; Nagai H; Hamashima Y
J Immunol Methods; 1984 Apr; 69(1):95-104. PubMed ID: 6371143
[TBL] [Abstract][Full Text] [Related]
5. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
[TBL] [Abstract][Full Text] [Related]
6. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
7. C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.
Huber C; Rüger A; Herrmann M; Krapf F; Kalden JR
Rheumatol Int; 1989; 9(2):59-64. PubMed ID: 2814209
[TBL] [Abstract][Full Text] [Related]
8. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
Olds LC; Miller JJ
Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
Xu RJ; Gu YA
J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
[TBL] [Abstract][Full Text] [Related]
11. Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy.
Yap HK; Sakai RS; Woo KT; Lim CH; Jordan SC
Clin Immunol Immunopathol; 1987 Jun; 43(3):395-402. PubMed ID: 3581518
[TBL] [Abstract][Full Text] [Related]
12. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
13. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
14. New ELISA kits using C3 binding glycoprotein from Cuscuta europea detect mainly IgM CIC in rheumatoid arthritis and progressive systemic sclerosis, but not in systemic lupus erythematosus.
Stanilova SA; Slavov ES
Clin Dev Immunol; 2003; 10(2-4):111-7. PubMed ID: 14768941
[TBL] [Abstract][Full Text] [Related]
15. IgA immune complexes in patients with dermatitis herpetiformis occur in the absence of IgA rheumatoid factor.
Hall RP; Eyre RW
J Invest Dermatol; 1987 Jul; 89(1):27-31. PubMed ID: 3298445
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporine A on circulating immune complexes in IgA nephropathy.
Lai KN; Lam CW; Cheng IK; Tam JS; Lai FM
Int Urol Nephrol; 1991; 23(3):265-74. PubMed ID: 1909692
[TBL] [Abstract][Full Text] [Related]
17. Significance of levels of circulating IgA-class immune complex in discriminant analysis of patients with IgA nephropathy before renal biopsy.
Yagame M; Suzuki D; Watanabe K; Nakao E; Eguchi K; Miyazaki M; Matsumoto Y; Yano N; Kuramoto T; Sakai H
Nephron; 1991; 57(4):433-8. PubMed ID: 2046826
[TBL] [Abstract][Full Text] [Related]
18. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
Jordan SC; Gautier E; Sakai R; Bahn L
J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin-antiimmunoglobulin interactions and immune complexes in IgA nephropathy.
Jackson S
Am J Kidney Dis; 1988 Nov; 12(5):425-9. PubMed ID: 3055969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
